ATE323161T1 - 5' ests für sekretierte proteine die im gehirn expremiert werden - Google Patents

5' ests für sekretierte proteine die im gehirn expremiert werden

Info

Publication number
ATE323161T1
ATE323161T1 AT98936594T AT98936594T ATE323161T1 AT E323161 T1 ATE323161 T1 AT E323161T1 AT 98936594 T AT98936594 T AT 98936594T AT 98936594 T AT98936594 T AT 98936594T AT E323161 T1 ATE323161 T1 AT E323161T1
Authority
AT
Austria
Prior art keywords
ests
secreted proteins
brain
proteins expressed
sequences
Prior art date
Application number
AT98936594T
Other languages
English (en)
Inventor
Milne Edwards Jean-Bapti Dumas
Aymeric Duclert
Bruno Lacroix
Original Assignee
Serono Genetics Inst Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Serono Genetics Inst Sa filed Critical Serono Genetics Inst Sa
Application granted granted Critical
Publication of ATE323161T1 publication Critical patent/ATE323161T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AT98936594T 1997-08-01 1998-07-31 5' ests für sekretierte proteine die im gehirn expremiert werden ATE323161T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/905,223 US6222029B1 (en) 1997-08-01 1997-08-01 5′ ESTs for secreted proteins expressed in brain

Publications (1)

Publication Number Publication Date
ATE323161T1 true ATE323161T1 (de) 2006-04-15

Family

ID=25420448

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98936594T ATE323161T1 (de) 1997-08-01 1998-07-31 5' ests für sekretierte proteine die im gehirn expremiert werden

Country Status (8)

Country Link
US (1) US6222029B1 (de)
EP (1) EP1000150B1 (de)
JP (1) JP2001512015A (de)
AT (1) ATE323161T1 (de)
AU (1) AU8555598A (de)
CA (1) CA2296667A1 (de)
DE (1) DE69834190T2 (de)
WO (1) WO1999006552A2 (de)

Families Citing this family (61)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6894146B1 (en) 1997-02-25 2005-05-17 Corixa Corporation Compositions and methods for the therapy and diagnosis of prostate cancer
US7202342B1 (en) 1999-11-12 2007-04-10 Corixa Corporation Compositions and methods for the therapy and diagnosis of prostate cancer
US6630305B1 (en) 1999-11-12 2003-10-07 Corixa Corporation Compositions and methods for the therapy and diagnosis of prostate cancer
US6395278B1 (en) 1997-02-25 2002-05-28 Corixa Corporation Prostate specific fusion protein compositions
US20030185830A1 (en) 1997-02-25 2003-10-02 Corixa Corporation Compositions and methods for the therapy and diagnosis of prostate cancer
US6800746B2 (en) 1997-02-25 2004-10-05 Corixa Corporation Compositions and methods for the therapy and diagnosis of prostate cancer
US6620922B1 (en) 1997-02-25 2003-09-16 Corixa Corporation Compositions and methods for the therapy and diagnosis of prostate cancer
US6943236B2 (en) 1997-02-25 2005-09-13 Corixa Corporation Compositions and methods for the therapy and diagnosis of prostate cancer
US6759515B1 (en) 1997-02-25 2004-07-06 Corixa Corporation Compositions and methods for the therapy and diagnosis of prostate cancer
US6818751B1 (en) 1997-08-01 2004-11-16 Corixa Corporation Compositions and methods for the therapy and diagnosis of prostate cancer
HUP0002095A3 (en) 1997-02-25 2002-02-28 Corixa Corp Seattle Compounds for immunotherapy of prostate cancer and methods for their use
US6329505B1 (en) 1997-02-25 2001-12-11 Corixa Corporation Compositions and methods for therapy and diagnosis of prostate cancer
US7517952B1 (en) 1997-02-25 2009-04-14 Corixa Corporation Compositions and methods for the therapy and diagnosis of prostate cancer
US7033827B2 (en) 1997-02-25 2006-04-25 Corixa Corporation Prostate-specific polynucleotide compositions
US6261562B1 (en) 1997-02-25 2001-07-17 Corixa Corporation Compounds for immunotherapy of prostate cancer and methods for their use
US6613872B1 (en) 1997-02-25 2003-09-02 Corixa Corporation Compounds for immunotherapy of prostate cancer and methods for their use
US6465611B1 (en) 1997-02-25 2002-10-15 Corixa Corporation Compounds for immunotherapy of prostate cancer and methods for their use
US7119190B2 (en) 1997-04-14 2006-10-10 Arena Pharmaceuticals, Inc. Endogenous and non-endogenous versions of human G protein-coupled receptors
US6555339B1 (en) 1997-04-14 2003-04-29 Arena Pharmaceuticals, Inc. Non-endogenous, constitutively activated human protein-coupled receptors
US6956108B2 (en) * 1997-06-16 2005-10-18 Genentech, Inc. PRO1184 antibodies
CA2248971A1 (en) * 1997-10-31 1999-04-30 Kyowa Hakko Kogyo Co., Ltd. .beta.1, 3-n-acetylglucosaminyltransferase, dna encoding it and its use
US6548633B1 (en) 1998-12-22 2003-04-15 Genset, S.A. Complementary DNA's encoding proteins with signal peptides
US7045612B2 (en) 1998-01-16 2006-05-16 Mcgill University Human methionine synthase reductase: cloning, and methods for evaluating risk of neural tube defects, cardiovascular disease, and cancer
WO1999054442A1 (en) * 1998-04-17 1999-10-28 Emory University Protein phosphatase methylesterase dna
AU2006202355B2 (en) * 1998-05-01 2009-08-20 Glaxosmithkline Biologicals Sa Neisseria meningitidis antigens and compositions
US6096526A (en) 1998-05-20 2000-08-01 Incyte Pharmaceuticals, Inc. Human nucleic acid methylases
US6825328B1 (en) * 1998-07-20 2004-11-30 Stephen W. Scherer Lafora's disease gene
DE69942803D1 (de) * 1998-07-22 2010-11-11 Smithkline Beecham Ltd Rotein änhelt, und dafür kodierende cdns
IL141330A0 (en) 1998-08-20 2002-03-10 Regeneron Pharma Dcr5, a bmp-binding protein and aplications thereof
US20030190669A1 (en) * 1998-12-30 2003-10-09 Genentech, Inc. Secreted and transmembrane polypeptides and nucleic acids encoding the same
JP2003521239A (ja) * 1999-04-09 2003-07-15 キュラジェン コーポレイション 新規ヒトタンパク質およびそれらをコードするポリヌクレオチド
JP2001269184A (ja) * 1999-06-28 2001-10-02 Takeda Chem Ind Ltd 新規タンパク質およびそのｄｎａ
ATE528392T1 (de) * 1999-06-28 2011-10-15 Yusuke Nakamura Neues protein und dessen dns
JP2003506032A (ja) * 1999-07-31 2003-02-18 ボード オブ リージェンツ， ザ ユニバーシティ オブ テキサス システム セントリン特異的ヒトプロテアーゼｓｅｎｐ１−３
ES2189560B1 (es) 1999-10-01 2005-01-01 Consejo Superior De Investigaciones Cientificas Dna polimerasa k, nuevo marcador tumoral.
IL149569A0 (en) * 1999-11-17 2002-11-10 Arena Pharm Inc Endogenous and non-endogenous versions of human g protein-coupled receptors
WO2001088119A1 (fr) * 2000-04-28 2001-11-22 Takeda Chemical Industries, Ltd. Nouvelle proteine recepteur couplee a une proteine g et adn associe
US6828097B1 (en) * 2000-05-16 2004-12-07 The Childrens Mercy Hospital Single copy genomic hybridization probes and method of generating same
NZ522406A (en) * 2000-05-16 2006-05-26 Childrens Mercy Hospital Single copy genomic hybridization probes and method of generating same
AU2001279313B2 (en) 2000-08-04 2007-03-01 Ampio Pharmaceuticals, Inc. Method of using diketopiperazines and composition containing them
US7048931B1 (en) 2000-11-09 2006-05-23 Corixa Corporation Compositions and methods for the therapy and diagnosis of prostate cancer
US7927597B2 (en) 2001-04-10 2011-04-19 Agensys, Inc. Methods to inhibit cell growth
EP2280030A3 (de) 2001-04-10 2011-06-15 Agensys, Inc. Nukleinsäuren und zugehörige Proteine für die Behandlung und den Nachweis von Krebs
US6902902B2 (en) 2001-11-27 2005-06-07 Arena Pharmaceuticals, Inc. Human G protein-coupled receptors and modulators thereof for the treatment of metabolic-related disorders
US20030018172A1 (en) * 2001-12-06 2003-01-23 Genentech, Inc. Secreted transmembrane polypeptides and nucleic acids encoding the same
ATE520981T1 (de) * 2002-10-02 2011-09-15 Dmi Biosciences Inc Diagnose und überwachung von krankheiten
CA3050734A1 (en) 2003-05-15 2004-12-02 Ampio Pharmaceuticals, Inc. Treatment of t-cell mediated diseases
EP1636258A2 (de) * 2003-06-10 2006-03-22 Xantos Biomedicine AG Angiogenischer faktor und inhibitoren davon
RU2007104022A (ru) * 2004-07-02 2008-08-10 Дженентек, Инк. (Us) Композиции для лечения неходжкинской лимфомы и способы их применения
WO2008097467A1 (en) * 2007-02-02 2008-08-14 University Of Vermont And State Agricultural College Anti-methylation-controlled j protein antibodies and uses thereof
WO2009146320A1 (en) 2008-05-27 2009-12-03 Dmi Life Sciences, Inc. Therapeutic methods and compounds
US8507496B2 (en) 2010-09-07 2013-08-13 Dmi Acquisition Corp. Treatment of diseases
EP2766029B1 (de) 2011-10-10 2020-03-25 Ampio Pharmaceuticals, Inc. Behandlung degenerativer gelenkerkrankungen
EA027343B1 (ru) 2011-10-10 2017-07-31 Ампио Фармасьютикалз, Инк. Имплантируемые устройства медицинского назначения с повышенной иммунной толерантностью и способы изготовления и имплантирования
CA2846394A1 (en) 2011-10-28 2013-05-02 Ampio Pharmaceuticals, Inc. Treatment of rhinitis
CN110812470A (zh) 2012-07-11 2020-02-21 佛蒙特大学及州农业学院 用于代谢调节的方法和组合物
BR112015020469A2 (pt) 2013-03-15 2020-01-28 Ampio Pharmaceuticals Inc Usos de da-dkp, composição e método para fornecimento de células-tronco a umindivíduo
AU2015305611B2 (en) 2014-08-18 2020-04-23 Ampio Pharmaceuticals, Inc. Treatment of joint conditions
JP6944373B2 (ja) 2015-02-18 2021-10-06 ユニバーシティ・オブ・バーモント・アンド・ステイト・アグリカルチュラル・カレッジＵｎｉｖｅｒｓｉｔｙ Ｏｆ Ｖｅｒｍｏｎｔ Ａｎｄ Ｓｔａｔｅ Ａｇｒｉｃｕｌｔｕｒａｌ Ｃｏｌｌｅｇｅ Ｍｃｊアゴニストおよびそれらに関する使用
US11389512B2 (en) 2015-06-22 2022-07-19 Ampio Pharmaceuticals, Inc. Use of low molecular weight fractions of human serum albumin in treating diseases
JP2018521130A (ja) 2015-07-10 2018-08-02 ユニバーシティ・オブ・バーモント・アンド・ステイト・アグリカルチュラル・カレッジＵｎｉｖｅｒｓｉｔｙ Ｏｆ Ｖｅｒｍｏｎｔ Ａｎｄ Ｓｔａｔｅ Ａｇｒｉｃｕｌｔｕｒａｌ Ｃｏｌｌｅｇｅ 薬物性疾患および状態を治療する方法および組成物

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0279582A3 (de) 1987-02-17 1989-10-18 Pharming B.V. DNA-Sequenzen die Proteine zwecks effizienter Abscheidung zur Milchdrüse leiten
JP3337748B2 (ja) 1992-09-25 2002-10-21 財団法人神奈川科学技術アカデミー 完全長ｃＤＮＡの合成方法、その中間体の製造方法及び完全長ｃＤＮＡを含む組換えベクターの製造方法
FR2733762B1 (fr) 1995-05-02 1997-08-01 Genset Sa Methode de couplage specifique de la coiffe de l'extremite 5' d'un fragment d'arnm et preparation d'arnm et d'adnc complet
US5707829A (en) 1995-08-11 1998-01-13 Genetics Institute, Inc. DNA sequences and secreted proteins encoded thereby

Also Published As

Publication number Publication date
WO1999006552A2 (en) 1999-02-11
EP1000150B1 (de) 2006-04-12
EP1000150A2 (de) 2000-05-17
JP2001512015A (ja) 2001-08-21
US6222029B1 (en) 2001-04-24
AU8555598A (en) 1999-02-22
WO1999006552B1 (en) 1999-06-03
DE69834190D1 (de) 2006-05-24
DE69834190T2 (de) 2007-01-11
CA2296667A1 (en) 1999-02-11
WO1999006552A3 (en) 1999-04-22

Similar Documents

Publication Publication Date Title
DE69834190D1 (de) 5' ests für sekretierte proteine die im gehirn expremiert werden
ATE338117T1 (de) 5' ests für proteine, die nicht gewebespezifisch sind
DE69842099D1 (de) 5' ESTs für sekretierte Proteine, die in verschiedenen Geweben exprimiert werden
ATE361933T1 (de) 5' ests für sekretierte proteine aus gehirngeweben
WO1999006550A3 (en) 5' ESTs FOR SECRETED PROTEINS EXPRESSED IN PROSTATE
WO1999053051A3 (en) 5' ests and encoded human proteins
EP1033401A3 (de) Exprimierte Sequenzmarker und kodierte menschliche Proteine
WO1999006554A3 (en) 5' ESTs FOR SECRETED PROTEINS EXPRESSED IN MUSCLE AND OTHER MESODERMAL TISSUES
ATE328078T1 (de) 5' ests für sekretierte proteine die in verschiedenen geweben expremiert werden
WO1999006439A3 (en) 5' ESTs FOR SECRETED PROTEINS EXPRESSED IN ENDODERM
DE69841110D1 (de) Verlängerte cdns, die für sekretierte proteine kodieren
WO1999025825A3 (en) EXTENDED cDNAs FOR SECRETED PROTEINS
WO1999040189A3 (en) Cdnas encoding secreted proteins
DE69633664D1 (de) Genetische marker für brust und eierstockkrebs
WO1999054461A3 (de) Menschliche nukleinsäuresequenzen aus endometriumtumorgewebe
DE69332668D1 (de) Beeinflussing der zelladhäsie durch oligonukleotide
WO1999054353A3 (de) Menschliche nukleinsäuresequenzen aus uterusnormalgewebe
WO1999054447A3 (de) Menschliche nukleinsäuresequenzen aus blasentumorgewebe
BG102878A (en) The use of genetic change in the gene of the human g-protein, 3-subunit for the diagnostics of diseases
ATE207536T1 (de) Nukleotid sequenzen und daraus abgleitete aminosäuresequenzen vom tumorgen int 6
黄威权 et al. Immunohistochemical and in situ hybridized histochemical studies of SP and SPmRNA in early human placenta
EP1903111A3 (de) Erweiterte cDNA für sekretierte Proteine

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties